Sanofi Genzyme Revenue and Competitors
Estimated Revenue & Valuation
- Sanofi Genzyme's estimated annual revenue is currently $1.9B per year. 0
- Sanofi Genzyme's total funding is $639M.
Sanofi Genzyme Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Sanofi Genzyme?
Genzyme General develops and markets therapeutic products and diagnostic products and services. Genzyme General has five therapeutic products on the market and a strong pipeline of products in development focused on the treatment of genetic disorders and other chronic debilitating diseases with well-defined patient populations. Genzyme General is a division of the biotechnology company Genzyme Corporation.keywords:N/A
Number of Employees
Employee Growth %
Sanofi Genzyme News
A startup that was spun out of Sanofi ADR in late 2019 is finally ready to share more about its work. Sionna Therapeutics, a cystic...
Sionna Therapeutics, a Sanofi Genzyme spinout, announced its launch with $111 million in Series B financing led by OrbiMed.
The life sciences giant Sanofi is now working from one of its two towers ... under the name Sanofi, subsuming offshoots like Sanofi Genzyme.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|